The Victoza approval comes after a priority review by the FDA, and shortly after Novo Nordisk reported the results of the phase 3 ELLIPSE trial which showed the drug was able to reduce haemoglobin ...
Victoza is one of five new generation diabetes ... It said awareness of GLP-1 receptor agonists has "significantly increased after unprecedented coverage in the media and on social media".
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback